Background: Desacyl ghrelin is acylated by ghrelin O-acyltransferase (GOAT) and converted to acyl ghrelin. To date, little is known about the relationship among the levels of these two forms of ghrelin, GOAT level, and insulin resistance in Asian individuals. The purpose of this study was to determine the relationship between insulin resistance and the levels of plasma acyl ghrelin, desacyl ghrelin, and GOAT in asymptomatic middle-aged Korean men. Methods: This cross-sectional study evaluated 78 asymptomatic middle-aged Korean men with metabolic syndrome (MS). We examined the correlation between the plasma levels of acyl ghrelin, desacyl ghrelin, and GOAT and sociodemographic, dietary, anthropometric, and metabolic parameters, as well as the association between insulin resistance and plasma levels of acyl ghrelin, desacyl ghrelin, and GOAT. Results: The levels of desacyl ghrelin and total ghrelin were significantly lower in the MS group than in the non-MS group (P<0.017, P=0.01, respectively). HOMA-IR values showed a significant negative correlation with desacyl ghrelin (r=-0.271, P=0.017) and total ghrelin (r=-0.271, P=0.016) levels. Acyl ghrelin and GOAT were not significantly correlated with HOMA-IR, and no correlation was found between the plasma levels of the two ghrelin types and GOAT. Conclusion: The plasma levels of desacyl ghrelin and total ghrelin in middle-aged Korean men with MS were lower than in those without MS. A significant negative correlation was observed between desacyl ghrelin level and HOMA-IR; however, no correlation was found between plasma levels of acyl ghrelin and GOAT and HOMA-IR.
INTRODUCTION
Ghrelin is a 28-amino acid peptide hormone that is primarily secreted by the gastric mucosa and is known to be involved in glucose metabolism, food intake, and energy homeostasis.
1,2 Low concentrations of total ghrelin are associated with obesity 3, 4 , insulin resistance 5, 6 , and metabolic syndrome. 7 However, ghrelin occurs in two major forms-acyl ghrelin and desacyl ghrelin1-and these forms have distinct metabolic effects. [8] [9] [10] [11] Several studies have evaluated both ghrelin forms and indicated that high level of acyl ghrelin and low level of desacyl ghrelin are associated with increased prevalence of metabolic syndrome (MS). 12, 13 The enzyme responsible for ghrelin acylation, ghrelin O-acyl-lieved to be involved in control of the metabolic state and glucose homeostasis. 14 Several studies have demonstrated that GOAT mRNA expression is regulated by energy balance and is dependent on the metabolic state. 15, 16 More recently, a cross-sectional study has found that human plasma GOAT protein level is positively correlated with body mass index (BMI) and negatively correlated with plasma level of total ghrelin. 17 The studies that evaluated the associations between the two ghrelin forms and metabolic syndrome had several limitations, including a relatively small sample size and the evaluation of Caucasian subjects only. However, there are many interethnic differences in underlying pathophysiological and lifestyle factors between
Asian and Caucasian individuals. In addition, little is known about the relationships between the levels of the two ghrelin forms, GOAT, and insulin resistance. Therefore, the aim of the present study was to identify the relationships between insulin resistance and the levels of acyl ghrelin, desacyl ghrelin, and GOAT in asymptomatic middle-aged Korean men.
METHODS

Study subjects and ethics
This cross-sectional study was approved by the Institutional Review Board of Pusan National University Yangsan Hospital (L-2013-230), and informed written consent was provided by all subjects before participating in the study. Only men were recruited in order to avoid the effects of the menstrual cycle and oral contraceptives on insulin sensitivity. The study subjects included 80 asymptomatic men aged 40 to 60 years who visited the health promotion center of Pusan National University Yangsan Hospital. Subjects had not taken any anti-diabetic drugs, steroids, or hormonal products.
Subjects with a history of malignancy or a cardiovascular event and subjects who received medication for acute diseases, including myocardial infarction and angina pectoris, were excluded. Ultimately, 78 middle-aged men were enrolled in the study.
Measurements
Height and weight were measured using standard protocols with the subjects wearing a light gown and no shoes. Acyl ghrelin and desacyl ghrelin were measured using a commercial ELISA kit (Cusabio Biotech, Wuhan, China). The inter-and intra-assay coefficients of variation (CV) were 7.0% and 5.2%, respectively, for acyl ghrelin and 8.6% and 6.5% for desacyl ghrelin.
Plasma GOAT level was measured using the Human GOAT ELI-SA Kit (Cusabio Biotech, Wuhan, China), and the inter-and intraassay CV were 7.6% and 5.8%, respectively.
Abdominal fat was assessed using computed tomography (CT) scans acquired at the L4-L5 level. Abdominal fat was defined as the area corresponding to the pixel range from -190 to -30 Hounsfield units. 18 The areas of visceral and subcutaneous abdominal adipose tissue were measured. Fat inside the peritoneum was considered visceral adipose tissue, and fat between the dermis and muscle fas-cia was considered subcutaneous adipose tissue. Whole body composition scans were obtained using a Hologic Discovery instrument (Hologic Inc., Bedford, MA, USA).
Both diet and physical activity were assessed because of their possible effects on insulin sensitivity. Diet was monitored by a semi-quantitative food frequency questionnaire 19 , and physical activity was assessed using the International Physical Activity Questionnaire. 20 Physical activity level was expressed in metabolic equivalent-(MET-) minutes. The homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated using the formula: [fasting plasma insulin (µU/mL) × fasting plasma glucose (mg/dL)]/(22.5 × 18.182).
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Definition of metabolic syndrome
MS was defined according to the 2005 American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI).
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The waist circumference threshold for abdominal obesity in Korean men is 90 cm.
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Statistical analysis
Descriptive data are expressed as means (standard deviation, SD) or numbers (%). The mean and SD of ghrelin level determined in a previous study 7 were used to calculate the statistical power for this study. At least 19 subjects per group would be required to fulfill these assumptions (power = 90%, alpha error = 0.05). We assumed a prevalence of MS of 25% in middle-aged men and a dropout rate of 5%. Therefore, 80 subjects were selected for the present study. The study subjects were divided into two groups: those that met the AHA/NHLBI criteria for MS (the MS group) and those that did not meet these criteria (the non-MS group 
RESULTS
The general characteristics of the study subjects are shown in Ta 
Sociodemographic, dietary, anthropometric, and metabolic parameters
No differences in age, alcohol consumption, physical activity, or dietary intake were observed between the MS and non-MS groups.
However, the prevalence of current smoking was significantly higher in the MS group (P= 0.009, Table 2 ).
BMI and WC were significantly higher in the MS group than in the non-MS group (P< 0.001 and P< 0.001, respectively). Similarly, the CT-measured abdominal visceral fat area and subcutaneous fat area were significantly higher in the MS group than in the non-MS group (P< 0.001 and P= 0.006, respectively). However, no dif- Data are expressed as means± SEs or numbers (%). P values were determined using the 2-sample t-test or the chi-square test. *P values were determined using the Mann-Whitney U test. MS, metabolic syndrome; VFA, visceral fat area; SFA, subcutaneous fat area; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostatic model assessment insulin resistance index; HDL, high-density lipoprotein; ALT, alanine aminotransferase; GGT, γ-glutamyl transferase; CRP, C-reactive protein; GOAT, ghrelin O-acyltransferase; DXA, dual-energy X-ray absorptiometry; CT, computed tomography. One MET is roughly equivalent to 1 kcal/min for a 60 kg person.
Ghrelin levels
Desacyl ghrelin and total ghrelin levels were significantly lower in the MS group (P < 0.017, P = 0.01, respectively). However, no significant differences in acyl ghrelin and GOAT levels were observed between the two groups ( Table 2 ).
The ROC curves of desacyl ghrelin, total ghrelin, GGT, and 
Correlations between HOMA-IR, desacyl ghrelin, acyl ghrelin, and GOAT
HOMA-IR values were significantly negatively correlated with desacyl ghrelin (r = -0.271, P = 0.017) and total ghrelin (r = -0.271, P = 0.016) ( Table 3 ), but not significantly correlated with acyl ghrelin or GOAT level. No correlations were found between acyl ghrelin, desacyl ghrelin, and GOAT levels.
DISCUSSION
In the present study, we investigated the associations between two types of ghrelin and MS in middle-aged Korean men. Desacyl ghrelin and total ghrelin levels in the MS group were lower than in the non-MS group; however, no intergroup difference in the levels of acyl ghrelin and GOAT were observed. Furthermore, a significant negative correlation was found between desacyl ghrelin and HOMA-IR, but no correlation was found between acyl ghrelin or GOAT and HOMA-IR.
Desacyl ghrelin is acylated by GOAT to form acyl ghrelin. Acyl ghrelin and desacyl ghrelin are detectable in the circulation at ratios of 1:4 to 1:9 depending on nutritional status and the sample collection method used. 1, 8 Acyl ghrelin exerts central and peripheral effects via growth hormone secretagogue receptor (GHSR) type 1a. 1 Desacyl ghrelin was initially believed to be an inactive form because it does not bind or activate GHSR. However, several studies have demonstrated that desacyl ghrelin antagonizes the inhibitory action of acyl ghrelin on insulin secretion independently of GHSR 10, 11 , although the desacyl ghrelin receptor has not been identified. Further investigation is needed to understand the actions of acyl ghrelin and desacyl ghrelin on pancreatic islet cell function.
Previous studies have shown that low total ghrelin level is associ- , and that circulating acyl ghrelin level is elevated in obesity and MS, whereas desacyl ghrelin level is diminished in these conditions. 12 However, we found no significant difference in acyl ghrelin levels between the MS and non-MS groups.
We believe that the failure to identify this difference was due the small intergroup difference in mean BMI (MS group, 26.4 kg/m 2 ; non-MS group, 23.9 kg/m 2 ). However, the present study focused on insulin resistance rather than obesity, and previous studies in mice and humans have shown that insulin-resistant subjects have lower levels of total ghrelin and desacyl ghrelin, which is consistent with our findings. 24, 25 These results indicate that insulin resistance reflects a relative deficiency in desacyl ghrelin, and that desacyl ghrelin plays an active role in the regulation of glucose and insulin metabolism.
GOAT, the enzyme responsible for ghrelin acylation, was discovered recently; therefore, few studies have evaluated the correlation between GOAT and ghrelin hormones. In a prospective intervention study in rats, GOAT and ghrelin mRNA levels in the stomach mucosa were found to be relatively stable during periods of decreased food intake. 15 However, in situations of chronic food restriction, GOAT and ghrelin mRNA levels were increased. 15 Moreover, a recent study evaluated the regulation of GOAT protein level under different metabolic conditions in the plasma of rats and mice by semi-quantitative Western blotting and found that an increase in circulating GOAT level increased ghrelin acylation in response to fasting. 16 More recently, a cross-sectional study conducted in 45 human subjects found that plasma GOAT protein level was positively correlated with BMI and negatively correlated with plasma total ghrelin. 17 Moreover, a semi-quantitative study indicated that plasma GOAT protein level was lower in anorexic subjects than in normal- 
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Because GOAT knockout mice that fasted for 16 hours had increased insulin secretion and improved glucose tolerance, GOAT is believed to play a major role in the regulation of insulin secretion and glucose metabolism. Accordingly, we expected that MS patients would have higher circulating GOAT level, and that GOAT level would correlate with HOMA-IR. However, our results showed no significant intergroup difference and no such correlation. We believe that this apparent discrepancy was caused by the inclusion of extreme metabolic groups in the previous study, including a group with anorexia nervosa and a group with morbid obesity (BMI > 50 kg/m 2 ). In addition, plasma GOAT level might not reflect GOAT mRNA level in the gastric mucosa. Herein, we did not assess GOAT mRNA level in the gastric mucosa and therefore could not assess the changes in GOAT mRNA expression.
This study has several limitations, including a relatively small-size cohort and a study population limited to relatively healthy middleaged men, the latter of which was included to circumvent various unmeasured confounding factors. In addition, the BMI range of our subjects was restricted, and patients with anorexia and morbid obesity were not included. Further studies involving subjects with a wider range of BMIs and severe metabolic disturbances are required. Furthermore, the study had a cross-sectional design; therefore, temporal relations between ghrelin profiles and insulin resistance and MS could not be determined. Nonetheless, we believe that our findings are meaningful because this study is the first to evaluate the relations between circulating protein levels of desacyl ghrelin, acyl ghrelin, and GOAT.
In conclusion, desacyl ghrelin and total ghrelin levels in middleaged Korean men with MS were lower than those in subjects without MS, and HOMA-IR was significantly and negatively correlated with desacyl ghrelin and total ghrelin, but not with acyl ghrelin or GOAT.
CONFLICTS OF INTEREST
The authors declare no conflict of interest.
